12.04.2016, 12:42
Ashland explores the culture, science and technology of personal care at in-cosmetics 2016
OREANDA-NEWS. Ashland Inc. (NYSE: ASH) today announced that it is enhancing its network of personal care centers of excellence around the world to better serve manufacturers of hair, skin and oral care products with ingredients and prototype formulations preferred by consumers in a specific culture, market or geographic area.
“Accounting for differences in the way consumers use personal care products around the world, variances in the perceptions of ingredients on different hair and skin types, the culture of populations, and varying climate, is key to the future success of the personal care industry,” said Linda Foltis, Ashland’s vice president of care specialties research and development. “In building out personal care R&D facilities around the world, we are better able to gain consumer insights and advance the science of personal care for our customers.”
Ongoing investments in sophisticated laboratories in key locations worldwide allow Ashland to conduct formulation, measurement science and clinical/consumer studies on both a regional and global basis. At the same time, regional and global marketing teams enable Ashland to see and understand the market activity and emerging trends in much of the world.
“Accordingly, Ashland now develops new ingredients for global and regional markets, whereby a global laboratory network provides support for regional market needs in the areas of formulation, market claims substantiation and clinical or consumer science studies. These data sets become a part of the Ashland global network and can be leveraged for use in other regions,” she said.
Ashland’s global technology network resides within its “Dimensions of Care” concept, where expertise in culture, science and ingredients come together to form a market-specific solution for customers.
At the in-cosmetics trade show today, live models representing various skin and hair types from around the world were on hand to demonstrate hairstyle, cosmetic, and skin beauty preferences based on prototypes containing Ashland ingredients.
Innovative new skin care ingredients
It is estimated that by 2020, approximately 5.9 billion people worldwide will have access to smartphones. Cellular phones and other devices emit what is known as blue light, a high-energy form of visible light in the violet/blue band that ranges from 400 to 500 nanometers. Ashland’s new Blumilight™ biofunctional addresses the skin-damaging potential of blue-light pollution emanating from cell phones, computer screens and natural sources. Blumilight is a first-of-itskind ingredient to help maintain the presence of blue-light-sensitive photoreceptors in skin, in vitro. Opsin photoreceptors mediate the conversion of a photon of light into an electrochemical signal.
“Blue light pollution from all sources is known to induce mitochondrial reactive oxygen species (ROS) and free radical production in epidermal cells,” said Anne-Francoise Clay, marketing manager, skin care biofunctionals, Ashland. “Studies conducted at Ashland’s VincienceTM Skin Research Center demonstrate that Blumilight offers antioxidant benefits, in vitro. Blumilight is associated with a very significant reduction in mitochondrial and cellular ROS induced by blue LED, in vitro.”
Ashland’s Blumilight is the first cocoa peptidic fraction on the market - a product derived from the seeds of premium (and sustainable) cocoa grown in Peru. The peptidic fraction is also the first skin care ingredient demonstrated to maintain opsin 1, opsin 2 and opsin 3, the lightactivated receptors expressed in epidermal skin that serve as photosensors. Other products in the market serve as UV/blue light filters situated at the top of skin.
“Accounting for differences in the way consumers use personal care products around the world, variances in the perceptions of ingredients on different hair and skin types, the culture of populations, and varying climate, is key to the future success of the personal care industry,” said Linda Foltis, Ashland’s vice president of care specialties research and development. “In building out personal care R&D facilities around the world, we are better able to gain consumer insights and advance the science of personal care for our customers.”
Ongoing investments in sophisticated laboratories in key locations worldwide allow Ashland to conduct formulation, measurement science and clinical/consumer studies on both a regional and global basis. At the same time, regional and global marketing teams enable Ashland to see and understand the market activity and emerging trends in much of the world.
“Accordingly, Ashland now develops new ingredients for global and regional markets, whereby a global laboratory network provides support for regional market needs in the areas of formulation, market claims substantiation and clinical or consumer science studies. These data sets become a part of the Ashland global network and can be leveraged for use in other regions,” she said.
Ashland’s global technology network resides within its “Dimensions of Care” concept, where expertise in culture, science and ingredients come together to form a market-specific solution for customers.
At the in-cosmetics trade show today, live models representing various skin and hair types from around the world were on hand to demonstrate hairstyle, cosmetic, and skin beauty preferences based on prototypes containing Ashland ingredients.
Innovative new skin care ingredients
It is estimated that by 2020, approximately 5.9 billion people worldwide will have access to smartphones. Cellular phones and other devices emit what is known as blue light, a high-energy form of visible light in the violet/blue band that ranges from 400 to 500 nanometers. Ashland’s new Blumilight™ biofunctional addresses the skin-damaging potential of blue-light pollution emanating from cell phones, computer screens and natural sources. Blumilight is a first-of-itskind ingredient to help maintain the presence of blue-light-sensitive photoreceptors in skin, in vitro. Opsin photoreceptors mediate the conversion of a photon of light into an electrochemical signal.
“Blue light pollution from all sources is known to induce mitochondrial reactive oxygen species (ROS) and free radical production in epidermal cells,” said Anne-Francoise Clay, marketing manager, skin care biofunctionals, Ashland. “Studies conducted at Ashland’s VincienceTM Skin Research Center demonstrate that Blumilight offers antioxidant benefits, in vitro. Blumilight is associated with a very significant reduction in mitochondrial and cellular ROS induced by blue LED, in vitro.”
Ashland’s Blumilight is the first cocoa peptidic fraction on the market - a product derived from the seeds of premium (and sustainable) cocoa grown in Peru. The peptidic fraction is also the first skin care ingredient demonstrated to maintain opsin 1, opsin 2 and opsin 3, the lightactivated receptors expressed in epidermal skin that serve as photosensors. Other products in the market serve as UV/blue light filters situated at the top of skin.
Комментарии